Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Yuhan Corporation
In ARM1, 32 subjects will be assigned and the subjects will be administered "comparator drug" at Day1/Day43 and "study drug" at Day22/64.
In ARM2, 32 subjects will be assigned and the subjects will be administered "study drug" at Day1/Day43 and "comparator drug" at Day22/64.
Age
19–55
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male with body mass index(BMI) between 18.5 and 30 kg/m2
Who has not suffered from clinically significant disease
Provision of signed written informed consent
You may not be if
History of and clinically significant disease
Administration of other investigational products within 3 months prior to the first dosing
Clareo Health | Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
